A costimulatory molecule-related signature in regard to evaluation of prognosis and immune features for clear cell renal cell carcinoma.

Hua, Xiaoliang; Ge, Shengdong; Zhang, Jiong; Xiao, Haibing; Tai, Sheng; Yang, Cheng; Zhang, Li; Liang, Chaozhao

Hua, Xiaoliang; Ge, Shengdong; Zhang, Jiong; Xiao, Haibing; Tai, Sheng; Yang, Cheng; Zhang, Li; Liang, Chaozhao.

Afiliação

Hua X; Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Ge S; Anhui Province Key Laboratory of Genitourinary Diseases, Anhui Medical University, Hefei, China.
Zhang J; The Institute of Urology, Anhui Medical University, Hefei, China.
Xiao H; Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Tai S; Anhui Province Key Laboratory of Genitourinary Diseases, Anhui Medical University, Hefei, China.
Yang C; The Institute of Urology, Anhui Medical University, Hefei, China.
Zhang L; Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Liang C; Anhui Province Key Laboratory of Genitourinary Diseases, Anhui Medical University, Hefei, China.

Cell Death Discov ; 7(1): 252, 2021 Sep 18.

Article em En | MEDLINE | ID: mdl-34537809

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article